CA2050473A1 - Inhibition du vih a l'aide de combinaisons synergiques de derivee de nucleosides - Google Patents

Inhibition du vih a l'aide de combinaisons synergiques de derivee de nucleosides

Info

Publication number
CA2050473A1
CA2050473A1 CA002050473A CA2050473A CA2050473A1 CA 2050473 A1 CA2050473 A1 CA 2050473A1 CA 002050473 A CA002050473 A CA 002050473A CA 2050473 A CA2050473 A CA 2050473A CA 2050473 A1 CA2050473 A1 CA 2050473A1
Authority
CA
Canada
Prior art keywords
dideoxy
hiv
ddi
derivative
nucleoside derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002050473A
Other languages
English (en)
Inventor
Vera Brankovan
Richard J. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2050473A1 publication Critical patent/CA2050473A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002050473A 1989-03-17 1990-03-16 Inhibition du vih a l'aide de combinaisons synergiques de derivee de nucleosides Abandoned CA2050473A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US324,934 1989-03-17
US40190889A 1989-09-01 1989-09-01
US401,908 1989-09-01

Publications (1)

Publication Number Publication Date
CA2050473A1 true CA2050473A1 (fr) 1990-09-18

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002050473A Abandoned CA2050473A1 (fr) 1989-03-17 1990-03-16 Inhibition du vih a l'aide de combinaisons synergiques de derivee de nucleosides

Country Status (19)

Country Link
EP (1) EP0464137A4 (fr)
JP (1) JPH04504850A (fr)
KR (1) KR920700653A (fr)
CN (1) CN1045791A (fr)
AU (1) AU5351490A (fr)
CA (1) CA2050473A1 (fr)
DD (1) DD301787A9 (fr)
FI (1) FI914367A0 (fr)
GR (1) GR1000618B (fr)
HU (1) HU208254B (fr)
IL (1) IL93783A0 (fr)
NO (1) NO913659L (fr)
NZ (1) NZ232912A (fr)
OA (1) OA09555A (fr)
PL (1) PL284343A1 (fr)
PT (1) PT93449A (fr)
WO (1) WO1990011081A1 (fr)
YU (1) YU53790A (fr)
ZW (1) ZW3290A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020344A1 (fr) * 1991-05-16 1992-11-26 Glaxo Group Limited Combinaisons antivirales contenant des analogues de nucleosides
JP2002518452A (ja) * 1998-06-24 2002-06-25 エモリ ユニバーシティ Hivの治療薬物の製造のための他の抗hiv薬と組み合わせた3’−アジド−2’,3’−ジデオキシウリジンの使用
US6914052B2 (en) 2001-03-15 2005-07-05 The Trustees Of Boston College Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (fr) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition du caractere infectieux et de l'effet cytopathique du htlv-iii/lav in vitro par la 2',3'-dideoxyinosine, 2',3'-dideoxyguanosine, ou 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
OA09555A (en) 1993-01-31
HU208254B (en) 1993-09-28
FI914367A0 (fi) 1991-09-17
JPH04504850A (ja) 1992-08-27
KR920700653A (ko) 1992-08-10
CN1045791A (zh) 1990-10-03
WO1990011081A1 (fr) 1990-10-04
HUT57988A (en) 1992-01-28
DD301787A9 (de) 1994-01-13
GR900100189A (en) 1990-07-31
PT93449A (pt) 1990-11-07
NZ232912A (en) 1992-06-25
GR1000618B (el) 1992-08-31
YU53790A (sh) 1993-05-28
EP0464137A4 (en) 1992-01-15
NO913659L (no) 1991-10-18
IL93783A0 (en) 1990-12-23
NO913659D0 (no) 1991-09-17
HU902898D0 (en) 1991-12-30
EP0464137A1 (fr) 1992-01-08
ZW3290A1 (en) 1990-11-07
PL284343A1 (en) 1991-06-03
AU5351490A (en) 1990-10-22

Similar Documents

Publication Publication Date Title
JP2656938B2 (ja) dsRNAと逆転写酵素インヒビターを含んで成るHIV感染治療のための医薬組成物
Coates et al. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro
Balzarini et al. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2', 3'-didehydro-2', 3'-dideoxyribonucleosides: a comparison with their parental 2', 3'-dideoxyribonucleosides.
Sarin et al. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone
Mitsuya et al. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2', 3'-dideoxynucleosides.
EP0291633B1 (fr) Utilisation de la 3'azido-3'-déoxythymidine pour le traitement ou la prophylaxie des infections humaines à rétrovirus
Mitsuya et al. Strategies for antiviral therapy in AIDS
EP0216510B1 (fr) Inhibition de l'infectivité in vitro et de l'effet cytopathique du HTLV-III/LAV par la 2'3'-didéoxyinosine, la 2'3'-didéoxyguanosine ou par la 2'3'-didéoxyadénosine
JPH0125A (ja) dsRNAと逆転写酵素インヒビターを含んで成るHIV感染治療のための医薬組成物
JP2001500471A (ja) プロテアーゼインヒビターの生物学的及び抗ウイルス活性を改善する方法
Hartmann et al. Enhanced in vitro inhibition of HIV-1 replication by 3′-fluoro-3′-deoxythymidine compared to several other nucleoside analogs
Baba et al. Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication invitro
AU630220B2 (en) Antiviral composition
EP0216511B1 (fr) Inhibition de l'infectivité in vitro et de l'effet cytopathique du HTLV-III/LAV par la 2'3'-didéoxycytidine
AU609099B2 (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
KR0141684B1 (ko) 2`,5`-올리고 아데닐레이트 유도체의 치료학적 이용
CA2050473A1 (fr) Inhibition du vih a l'aide de combinaisons synergiques de derivee de nucleosides
Wondrak et al. Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases α, β and γ by phosphonoformic acid and other drugs
AU623910B2 (en) Chemotherapeutic composition for aids
Jeffries Targets for antiviral therapy of human immunodeficiency virus infection
WO1988003804A2 (fr) Procede pour traiter des infections virales chez des humains, et compositions a cet effet
EP0493378A1 (fr) Utilisation de la 2',3'-dideoxyguanosine pour le traitement du SIDA
IE19940570A1 (en) Use of 2',3'-dideoxyguanosine for the treatment of AIDS
IL85096A (en) Use of (3-azido- (3-deoxythymidine) in the treatment or prevention of infections caused by human viruses
Broder Potential Mechanisms of Action Against HIV

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19940916